Diebold Nixdorf, Incorporated (DBD)
(Delayed Data from NYSE)
$56.89 USD
-3.16 (-5.26%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $56.79 -0.10 (-0.18%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth B Momentum A VGM
Diebold Nixdorf, Incorporated - Hold
Zacks' proprietary data indicates that Diebold Nixdorf, Incorporated is currently rated as a Zacks Rank 3 and we are expecting an inline return from the DBD shares relative to the market in the next few months. In addition, Diebold Nixdorf, Incorporated has a VGM Score of A (this is a weighted average of the individual Style Scores which allow you to focus on the stocks that best fit your personal trading style). Valuation metrics show that Diebold Nixdorf, Incorporated may be undervalued. Its Value Score of A indicates it would be a good pick for value investors. The financial health and growth prospects of DBD, demonstrate its potential to outperform the market. It currently has a Growth Score of B. Recent price changes and earnings estimate revisions indicate this would be a good stock for momentum investors with a Momentum Score of B.
Style Scorecard
Zacks News for DBD
Is It Worth Investing in Diebold Nixdorf, Incorporated (DBD) Based on Wall Street's Bullish Views?
DBD: What are Zacks experts saying now?
Zacks Private Portfolio Services